BlackSky Technology Inc. Class A (BKSY)
Live price chart, market sentiment, and community perspectives for BlackSky Technology Inc. Class A (NYSE: BKSY).
Live price chart, market sentiment, and community perspectives for BlackSky Technology Inc. Class A (NYSE: BKSY).
On our desk, the valuation debate for BKSY is intense. With the stock floating around $20 to $22 and a raised full-year 2026 revenue guidance of $130 million to $150 million, consensus is split between those pricing in high growth expectations from Gen-3 deployment and those looking at the trailing net loss of $66.7 million. We are carefully weighing the P/S multiple against accelerating defense contracts.
From a technical evaluation standpoint, BlackSky's operational deployment of its fourth Gen-3 satellite and first light imagery within hours of launch is impressive. Their ability to deliver 35-centimeter resolution imagery combined with the Spectra AI analytics platform gives them a clear tactical advantage for warfighters and major international Ministry of Defense clients.
Watching the 50-day moving average drop below the 200-day moving average in August 2026 flashed a clear technical warning sign for our book. While the fundamental narrative touts a 50% year-over-year revenue increase in Q2 and rapid Gen-3 tactical ISR adoption, the technical trend has shifted lower, suggesting that short-term downside momentum could outweigh the long-term growth thesis.
Our hedge fund analysts are closely watching the contract expansion velocity. The rapid scaling from a Gen-3 pilot to nearly a $30 million annual subscription with a major international defense customer validates their land-and-expand strategy. However, we remain cautious about unpredictable sales cycles and fixed-price contract resource estimates noted in their SEC disclosures.
Looking at the balance sheet highlights a total cash position of $234.18 million against total liabilities of roughly $290 million as of mid-2026. Despite a robust cash cushion, the risk of shareholder dilution noted in recent risk disclosures keeps us vigilant, especially given historical negative operating cash flows and a high beta of 2.61.
In our quantitative assessment of BKSY, the disconnect between DCF fair value models—ranging from Simply Wall St's estimate of $55.84 down to consensus overvaluation flags—creates a complex trading environment. The recent downgrade by Jefferies to a Hold rating with a $50 target reflects the market digestion following a substantial multi-month rally.
Explore plasma cleansing, somatic organ swaps, and BCI.